Sponsor pipeline

Epizyme, Inc. clinical trial pipeline

Get alerts when Epizyme, Inc.'s trials change

1 active trials 0 recruiting 1 Phase 3 1 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-11
Primary endpoint(s) modified
NCT04224493 A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of… · Phase 3

Active trials by phase

Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04224493 A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of… Relapsed/Refractory Follicular Lymphoma Active, Not Recruiting 2026-08-10

Disease areas by active trials

Follicular Lymphoma (1)

Get alerts when Epizyme, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free